O Domhnaill Enterprises Inc. Invests $1.21 Million in The Clorox Company $CLX

O Domhnaill Enterprises Inc. bought a new stake in shares of The Clorox Company (NYSE:CLX) in the first quarter, HoldingsChannel.com reports. The institutional investor bought 11,719 shares of the company’s stock, valued at approximately $1,214,000.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in Clorox by 4.0% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 13,380 shares of the company’s stock valued at $1,970,000 after buying an additional 514 shares in the last quarter. Woodline Partners LP raised its holdings in Clorox by 253.7% in the 1st quarter. Woodline Partners LP now owns 10,407 shares of the company’s stock worth $1,532,000 after acquiring an additional 7,465 shares during the last quarter. Baird Financial Group Inc. lifted its holdings in shares of Clorox by 1.7% during the second quarter. Baird Financial Group Inc. now owns 25,032 shares of the company’s stock valued at $3,006,000 after purchasing an additional 424 shares in the last quarter. Jump Financial LLC increased its holdings in Clorox by 173.5% in the 2nd quarter. Jump Financial LLC now owns 12,491 shares of the company’s stock worth $1,500,000 after buying an additional 7,924 shares in the last quarter. Finally, Bank of Nova Scotia lifted its stake in Clorox by 26.2% during the 2nd quarter. Bank of Nova Scotia now owns 16,141 shares of the company’s stock valued at $1,938,000 after acquiring an additional 3,352 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Insider Activity

In other news, Director Pierre R. Breber acquired 5,000 shares of Clorox stock in a transaction dated Tuesday, May 5th. The stock was purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares in the company, valued at $1,544,760. This trade represents a 38.46% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.63% of the company’s stock.

Clorox Trading Up 1.8%

Shares of NYSE CLX traded up $1.72 during trading hours on Tuesday, hitting $98.97. 364,526 shares of the company traded hands, compared to its average volume of 2,533,317. The company’s 50 day moving average price is $94.22 and its 200 day moving average price is $104.24. The Clorox Company has a 12 month low of $84.70 and a 12 month high of $132.03. The stock has a market capitalization of $11.97 billion, a price-to-earnings ratio of 16.02, a price-to-earnings-growth ratio of 0.46 and a beta of 0.54. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03.

Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The company had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same period in the previous year, the company earned $1.45 EPS. The firm’s quarterly revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, equities research analysts anticipate that The Clorox Company will post 5.61 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

CLX has been the topic of a number of research reports. Jefferies Financial Group dropped their price target on Clorox from $139.00 to $125.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. The Goldman Sachs Group reiterated a “sell” rating and issued a $83.00 price objective on shares of Clorox in a research note on Friday, May 1st. JPMorgan Chase & Co. decreased their price target on shares of Clorox from $99.00 to $95.00 and set an “underweight” rating on the stock in a research report on Friday, May 1st. BNP Paribas Exane reduced their price objective on Clorox from $128.00 to $97.00 and set a “neutral” rating for the company in a research note on Tuesday, May 12th. Finally, Zacks Research cut Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, May 12th. One investment analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and a consensus price target of $103.40.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.